The Food and Drug Administration (FDA) last Friday (March 11) granted the emergency use authorization (EUA) for Pfizer’s anti-viral COVID-19 pill Paxlovid.
FDA Deputy Director-General Oscar Gutierrez, also the officer-in-charge, said the FDA also granted an EUA to another pill brand Molenzavir manufactured in Bangladesh.
Earlier, health authorities also approved a compassionate permit for Bexovid, the generic version of Paxlovid. (PTV News/PG)
